Insider Shareholders with Direct Ownership of Gain Therapeutics, Inc. (GANX)
This section provides a comprehensive overview of the insiders with direct ownership of Gain Therapeutics, Inc. (GANX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Gain Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Eric I Richman
Director |
92,560 | 0 | 289,629 $640,080 | 6 |
Jul 01, 2024
Added 3.98%
|
|
Khalid Islam
Executive Chairman |
50,000 | 0 | 50,000 $110,500 | 1 |
Aug 09, 2024
Added 50.0%
|
|
Jeffrey Scott Riley
Director |
30,000 | 0 | 30,000 $66,300 | 1 |
Mar 28, 2024
Added 50.0%
|
|
Matthias Alder
Chief Executive Officer |
27,524 | 8,111 | 21,140 $46,719 | 8 |
Mar 26, 2024
Reduced 22.35%
|
|
Gene Mack
CFO and Interim CEO |
14,400 | 0 | 14,400 $31,824 | 1 |
Aug 09, 2024
Added 50.0%
|
|
Salvatore Calabrese
Chief Financial Officer |
3,000 | 0 | 8,100 $17,901 | 1 |
May 19, 2022
Added 27.03%
|